NCT00753142View on ClinicalTrials.gov

Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Intralipid 20%

Participants receive a 48-hour infusion with Intralipid at 40 milliliters per hour (mL/hr).

DRUG

Glucose infusion

Participants receive a glucose infusion consisting of 10% dextrose infused intravenously at a rate of 200 mg/m\^2/min for 20 hours.

Trial Locations (1)

30303

Grady Memorial Hospital, Atlanta

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

lead

Emory University

OTHER

NCT00753142 - Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises | Biotech Hunter | Biotech Hunter